Andere Sprachen Gland Pharma Limited Bombay S.E.

Aktien

A2QG5F

INE068V01023

GLAND

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:52 28.06.2024			% 5 Tage	% 1. Jan.
1’824 ^INR	+0.37%		+0.60%	-5.15%

20.06.	Fosun Pharma reduziert Beteiligung an Gland Pharma auf 51,83%	MT
18.06.	Fosun Pharma Industrial trennt sich angeblich für 172 Millionen Dollar von 5% der Anteile an Gland Pharma	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Fosun Pharma Trims Stake in Gland Pharma to 51.83%	20.06.
Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million	18.06.
Gland Pharma Limited Announces Management Changes	07.06.
Gland Pharma Limited Announces Resignation of C.S. Venkatesan as Sr. Vice President (R&D) and SMP, Effective June 30, 2024 and July 1, 2024 Respectively	31.05.
Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India	24.05.
Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit	23.05.
Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024	22.05.
Gland Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	22.05.
Gland Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	22.05.
Gland Pharma Gets US FDA's Approval for Generic ALS Drug	07.05.
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Edaravone Injection	07.05.
Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection	07.05.
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Plerixafor Injection	07.05.
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	06.05.
Gland Pharma Names COO	29.04.
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024	29.04.
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	29.04.
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection	29.04.
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals	08.04.
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection	08.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Gland Pharma Limited Bombay S.E.

Aktien

A2QG5F

INE068V01023

GLAND

Andere Sprachen

Filter